Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 15;230(5):e1007-e1011.
doi: 10.1093/infdis/jiae424.

Residency in Long-Term Care Facilities: An Important Risk Factor for Respiratory Syncytial Virus Hospitalization

Angela R Branche  1 , Ann R Falsey  1 , Lyn Finelli  2 , Edward E Walsh  1
Affiliations

Residency in Long-Term Care Facilities: An Important Risk Factor for Respiratory Syncytial Virus Hospitalization

Angela R Branche et al. J Infect Dis. .

Abstract

Older age and comorbid conditions increase risk for severe for respiratory syncytial virus (RSV). Skilled nursing facilities (SNFs) and assisted living (AL) facilities represent an intersection of risk factors. In a 3-year prospective study in Rochester, New York, we compared the population-based incidence of RSV-associated hospitalization for community-dwelling (CD), SNF, and AL adults aged ≥65 years. Their median ages were 76, 83 and 86 years, respectively, and dementia and congestive heart failure (CHF) were more prevalent among SNF and AL residents. The average annual incidences were 117 (95% confidence interval, 104-132), 440 (307-629) and 740 per 100 000 persons (523-1045), respectively, for CD, SNF, and AL adults aged ≥65 years, demonstrating a need for unequivocal RSV vaccine recommendations in SNF and AL residents.

Keywords: RSV hospitalization; RSV population-based incidence; RSV vaccine; Skilled Nursing Facilities; long-term care facilities.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. A. R. B. reports grant funding from Moderna, Cyanvac, Pfizer, Vaccitech, and Merck and serves as a consultant for Novavax, Sanofi, Merck, and GlaxoSmithKline. A. R. F. reports grant funding from Moderna, AstraZeneca, Cyanvac, Pfizer, and Vaccitech and serves as a consultant for GlaxoSmithKline, Moderna, Merck, and AstraZeneca. L. F. was an employee of Merck Sharp & Dohme, a subsidiary of Merck & Co, when the study was conducted. E. E. W. reports grant funding from Moderna, AstraZeneca, Cyanvac, Pfizer, Merck, and Vaccitech and serves as a consultant for GlaxoSmithKline, Moderna, Pfizer, Merck, and AstraZeneca. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Figure 1.
Figure 1.
Mean annual incidence of respiratory syncytial virus (RSV)–associated hospitalization per 100 000 persons in Rochester, New York, over 3 winter seasons, 2017–2018, 2018–2019, and 2019–2020. The 95% confidence intervals for the point estimates are represented by vertical black bars. Abbreviations: AL, assisted living; CD, community-dwelling; SNF, skilled nursing facility.
See this image and copyright information in PMC

References

    1. Melgar M, Britton A, Roper LE, et al. . Use of respiratory syncytial virus vaccines in older adults: recommendations of the advisory committee on immunization practices—United States, 2023. MMWR Morb Mortal Wkly Rep 2023; 72:793–801. - PMC - PubMed
    1. Branche AR, Saiman L, Walsh EE, et al. . Incidence of respiratory syncytial virus infection among hospitalized adults, 2017–2020. Clin Infect Dis 2022; 74:1004–11. - PubMed
    1. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749–59. - PubMed
    1. Havers FP, Whitaker M, Melgar M, et al. . Characteristics and outcomes among adults aged ≥60 years hospitalized with laboratory-confirmed respiratory syncytial virus—RSV-NET, 12 states, July 2022-June 2023. Am J Transplant 2023; 23:2000–7. - PMC - PubMed
    1. Zheng Z, Warren JL, Shapiro ED, Pitzer VE, Weinberger DM. Estimated incidence of respiratory hospitalizations attributable to RSV infections across age and socioeconomic groups. Pneumonia (Nathan) 2022; 14:6. - PMC - PubMed

Grants and funding